¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѰǼ±ÇÐȸ Á¦11ȸ °Ç¼± »ý¹°ÇÐÁ¦Á¦ ½ÉÆ÷Áö¾ö : 2023-12-02

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѰǼ±ÇÐȸ Á¦11ȸ °Ç¼± »ý¹°ÇÐÁ¦Á¦ ½ÉÆ÷Áö¾ö : 2023-12-02
±³À°ÀÏÀÚ : 2023-12-02
±³À°Àå¼Ò : " »ïÁ¤È£ÅÚ 2Ãþ ¶óº¥´õȦ"

±³À°ÁÖÁ¦ : "Á¦11ȸ °Ç¼± »ý¹°ÇÐÁ¦Á¦ ½ÉÆ÷Áö¾ö"

ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѰǼ±ÇÐȸ

´ã´çÀÚ : ÃÖÀ¯¼º ±³¼ö(±âȹÁ¤Ã¥ÀÌ»ç)
¿¬¶ôó : 02-709-9368

À̸ÞÀÏ : cardura@naver.com

±³À°Á¾·ù : ÇǺΰú

Âü¼®¿¹»óÀÎ : 70¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 0¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 12¿ù 02ÀÏ ¶óº¥´õȦ 13:00~13:30 Basic science of neutrophils in psoriasis È«Àå¿ø(°æºÏÀÇ´ë »ý¸®Çб³½Ç)

±³À°½Ã°£ 12¿ù 02ÀÏ ¶óº¥´õȦ 13:30~14:00 Mastering strategies to managing palmoplantar pustulosis Á¶¼ºÁø(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ¶óº¥´õȦ 14:00~14:30 Generalized pustular psoriasis as a rare and extreme form ±èűÕ(¿¬¼¼ÀÇ´ë)

Åä·Ð 12¿ù 02ÀÏ ¶óº¥´õȦ 14:30~14:40 Q&A È«Àå¿ø, Á¶¼ºÁø, ±èűÕ(°æºÏÀÇ´ë, ¼­¿ïÀÇ´ë, ¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ¶óº¥´õȦ 14:40~15:10 Role of TYK2 Pathway in Psoriasis À̽ÂÈ¿(KAIST)

±³À°½Ã°£ 12¿ù 02ÀÏ ¶óº¥´õȦ 15:10~15:40 Clinical data from TYK2 inhibitor in treatment of Posirasis ¹æöȯ(Ä«Å縯ÀÇ´ë)

Åä·Ð 12¿ù 02ÀÏ ¶óº¥´õȦ 15:40~15:50 Q&A À̽ÂÈ¿, ¹æöȯ(KAIST, Ä«Å縯ÀÇ´ë)

ÈÞ½Ä 12¿ù 02ÀÏ ¶óº¥´õȦ 15:50~16:10 ÈÞ½Ä ()

±³À°½Ã°£ 12¿ù 02ÀÏ ¶óº¥´õȦ 16:10~16:40 Patients with psoriasis resistant to multiple biological therapies Á¤±âÇå(°æÈñÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ¶óº¥´õȦ 16:40~17:10 Biologic tapering for patients with psoriasis with low disease activity ±èµ¿Çö(Â÷ÀÇ´ë)

Åä·Ð 12¿ù 02ÀÏ ¶óº¥´õȦ 17:10~17:20 Q&A Á¤±âÇå, ±èµ¿Çö(°æÈñÀÇ´ë, Â÷ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѰǼ±ÇÐȸ Á¦11ȸ °Ç¼± »ý¹°ÇÐÁ¦Á¦ ½ÉÆ÷Áö¾ö : 2023-12-02""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦7Â÷ ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ Á¤·®Àû °ñ¼Õ»ó ¿µ»óÆò°¡ ¿öÅ©¼ó : 2023-12-02
´ÙÀ½±Û ºñ´¢ÀÇÇаú ÃÖ½ÅÁö°ß ¹× Áõ·Ê ¹ßÇ¥ : 2023-12-02
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20805 ¼­¿ï 2024 ´ëÇÑ»ê°ú¸¶ÃëÇÐȸ Á¦27Â÷ Çмú´ëȸ : 2024-06-15 0 3 2024-05-27
20804 ÃæºÏ 204 ÃæûºÏµµÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-06-15 0 4 2024-05-27
20803 ºÎ»ê 2024³â Á¦7ȸ ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ Áý´ãȸ : 2024-06-15 0 2 2024-05-27
20802 ºÎ»ê 2024³â ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ ¿öÅ©¼¥-±â´ÉÀû Æò°¡ ¹× ÁßȯÀÚ ÀçÈ°ÀÇ ½ÇÁ¦ (¿Ü»ó ÁßȯÀÚ Æ÷ÇÔ) : 2024-06-15 0 5 2024-05-27
20801 ¼­¿ï KLASS 20Áֳ⠱â³ä 2024 ´ëÇѺ¹°­°æÀ§Àå°ü¿¬±¸È¸ Á¦27ȸ Á¤±âÇмú´ëȸ : 2024-06-15 0 2 2024-05-27
20800 °æ±â 2024³â Á¦ 3ȸ Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-15 0 2 2024-05-27
20799 ¼­¿ï (¿Â¶óÀÎ) 2024³âµµ ÀÓ»óÁø·áÁöħ Æò°¡À§¿ø ¾ç¼º±³À° : 2024-06-15 0 1 2024-05-27
20798 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾÆû¼Ò³â°ú ºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-15 0 0 2024-05-27
20797 ¼­¿ï ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ COPD School 2024 : 2024-06-15 0 0 2024-05-27
20796 ¼­¿ï »óóÀå·ç¿¬±¸È¸ Áý´ãȸ : 2024-06-15 0 0 2024-05-27
20795 Àü³² 2024³â Àü¶ó³²µµÀÇ»çȸ Àü¹Ý±â Çмú´ëȸ : 2024-06-15 0 2 2024-05-27
20794 ¼­¿ï Ç÷°ü¿µ»ó»ý¸®¿¬±¸È¸ IPOP(Imaging and Physiology on Patients with Cardiovascular Disease) 2024 : 2024-06-15 0 0 2024-05-27
20793 ¼­¿ï ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ¾à¹°¾Ë·¹¸£±â ½ÉÆ÷Áö¾ö : 2024-06-15 0 2 2024-05-27
20792 ´ëÀü ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ´ëÀü, ÃæûÁöȸ - Á¦3Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-15 0 0 2024-05-27
20791 ¼­¿ï Á¦51ȸ ´ëÇÑÀÓ»óÇǺÎÄ¡·á¿¬±¸È¸ ±³À°½ÉÆ÷Áö¾ö : 2024-06-15 0 4 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷